Remdesivir Is A Prodrug Of An adenosine Triphosphate (ATP) Analog, With Potential Antiviral Activity Against A Variety Of RNA Viruses. Upon Administration, Remdesivir, Being A Prodrug, Is Metabolized Into Its Active Form GS-441524. As An ATP analog, GS-441524 competes With ATP for Incorporation Into RNA And Inhibits The Action Of Viral RNA-dependent RNA Polymerase. This Results In The Termination Of RNA Transcription And Decreases Viral RNA Production.